Search results for Romilkimab
Romilkimab Biosimilar – Anti-IL13, IL4 mAb – Research Grade, ProteoGenix, PX-TA1027
Description of Romilkimab Biosimilar - Anti-IL13, IL4 mAb - Research Grade General information about Romilkimab Romilkimab is an engineered, humanised, bispecific immunoglobulin-G4 antibody that binds and neutralizes IL-4/IL-13 making it ideal for exploration in fibrosis, This product is for research use only.
Host
Reactivity
Applications
Conjugation
Romilkimab, Abbexa, abx831461
Romilkimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL13/IL4, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Research Grade Romilkimab (HW632046), abinScience, HW632046
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.